SAN JOSE — Arson investigators are looking into the cause of a fire spurred by a pickup truck crash that spread to a non-operational historic water park Saturday afternoon, authorities said. The crash ...

HAVANA ― Cuban housewife Yuamilka Hechavarria was asleep last Tuesday when water rushed into the cistern of the crumbling tenement where she lives in old Havana. She jumped from bed, scrambling in the ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Garbage along a street as people go about their daily activities, amid a US-imposed oil blockade that has contributed ...

HAVANA, Sept 30 (Reuters) - Cuban housewife Yuamilka Hechavarria was asleep last ⁠Tuesday ⁠when water rushed into the cistern of the ⁠crumbling tenement where she lives in old Havana. She jumped from ...

Water started flowing again to Jones Valley residents on Monday, Oct. 5, but Shasta County Department of Public Works officials asked that Jones Valley customers continue to boil their water a little ...

"Plaintiffs' suit fails because they seek to use American courts as a sword against Ofcom rather than as a shield to protect themselves." From Judge Rudolph Contreras (D.D.C.) last week in 4chan ...

AUSTIN, Texas (KXAN) — Gov. Greg Abbott (R) said this week he is directing the Texas Water Development Board to penalize data centers that fail to enforce state water-use reporting requirements. The ...

Circle and Coinbase shares fell about 10% as the failed Senate vote weighed on crypto-linked equities, with Bitcoin miners and treasury companies also declining. Crypto-linked stocks fell sharply on ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Novartis shares fell the most in a single day since the COVID-19 pandemic after the pharma giant acknowledged that its neuromuscular candidate delpacibart etedesiran (del-desiran) failed a pivotal ...

Evommune said its Phase 2b trial of a treatment for people with atopic dermatitis failed to meet its primary and secondary endpoints. The stock dropped 32%, to $8.95, in after-hours trading Tuesday.